The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents

Cancer Treat Rev. 1990 Sep;17(2-3):165-7. doi: 10.1016/0305-7372(90)90042-e.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Bleomycin / adverse effects
  • Cyclophosphamide / adverse effects
  • DNA Damage
  • Fibronectins / genetics
  • Fibronectins / metabolism
  • Lung / drug effects
  • Lung / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Procollagen / genetics
  • Procollagen / metabolism
  • Pulmonary Fibrosis / chemically induced*
  • Pulmonary Fibrosis / genetics
  • Pulmonary Fibrosis / metabolism
  • RNA, Messenger / metabolism
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism

Substances

  • Antineoplastic Agents
  • Fibronectins
  • Procollagen
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Bleomycin
  • Cyclophosphamide